Literature DB >> 19644855

Hypoxia and glucocorticoid signaling converge to regulate macrophage migration inhibitory factor gene expression.

Laura M Elsby1, Rachelle Donn, Zaynab Alourfi, Laura M Green, Elaine Beaulieu, David W Ray.   

Abstract

OBJECTIVE: Macrophage migration inhibitory factor (MIF) is a proinflammatory mediator involved in the pathogenesis of rheumatoid arthritis. This study was undertaken to identify the MIF promoter elements responsible for regulating gene expression.
METHODS: Luciferase reporter gene assays were used to identify the MIF promoter sequence responsible for basal activity. Bioinformatic analysis was used to predict transcription factor binding sites, and electrophoretic mobility shift assay (EMSA) was used to demonstrate transcription factor binding. Chromatin immunoprecipitation (ChIP) was used to demonstrate transcription factor loading on the MIF promoter.
RESULTS: We identified the minimal promoter sequence required for basal MIF promoter activity that was also capable of conferring glucocorticoid-dependent inhibition in a T lymphocyte model cell line. Deletion studies and EMSA revealed 2 elements in the MIF promoter that were responsible for basal promoter activity. The 5' element binds CREB/activating transcription factor 1, and the 3' element is a functional hypoxia-responsive element binding hypoxia-inducible factor 1alpha. Further studies demonstrated that the cis elements are both required for glucocorticoid-dependent inhibition. ChIP demonstrated glucocorticoid-dependent recruitment of glucocorticoid receptor alpha to the MIF promoter in lymphocytes within 1 hour of treatment and a concomitant decrease in acetylated histone H3.
CONCLUSION: Our findings indicate that hypoxia and glucocorticoid signaling converge on a single element regulating MIF; this regulatory unit is a potential interacting node for microenvironment sensing of oxygen tension and glucocorticoid action in foci of inflammation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19644855      PMCID: PMC4116773          DOI: 10.1002/art.24659

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  44 in total

1.  Assembly of transcription factor IIB at a promoter in vivo requires contact with RNA polymerase II.

Authors:  Laura M Elsby; Amanda J M O'Donnell; Laura M Green; Andrew D Sharrocks; Stefan G E Roberts
Journal:  EMBO Rep       Date:  2006-07-28       Impact factor: 8.807

Review 2.  Hypoxia and angiogenesis in rheumatoid arthritis.

Authors:  Peter C Taylor; Bran Sivakumar
Journal:  Curr Opin Rheumatol       Date:  2005-05       Impact factor: 5.006

3.  Target cells for an immunosuppressive cytokine, glycosylation-inhibiting factor.

Authors:  K Sugie; T Tomura; K Takakura; T Kawano; M Taniguchi; H M Grey; K Ishizaka
Journal:  Int Immunol       Date:  1999-07       Impact factor: 4.823

4.  Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids.

Authors:  M Leech; C Metz; P Hall; P Hutchinson; K Gianis; M Smith; H Weedon; S R Holdsworth; R Bucala; E F Morand
Journal:  Arthritis Rheum       Date:  1999-08

5.  High expression of macrophage migration inhibitory factor in the synovial tissues of rheumatoid joints.

Authors:  S Onodera; H Tanji; K Suzuki; K Kaneda; Y Mizue; A Sagawa; J Nishihira
Journal:  Cytokine       Date:  1999-02       Impact factor: 3.861

6.  Dual regulation of macrophage migration inhibitory factor (MIF) expression in hypoxia by CREB and HIF-1.

Authors:  John A Baugh; Michael Gantier; Lili Li; Aileen Byrne; Avril Buckley; Seamas C Donnelly
Journal:  Biochem Biophys Res Commun       Date:  2006-07-07       Impact factor: 3.575

7.  Glucocorticoids suppress macrophage migration inhibitory factor (MIF) expression in a cell-type-specific manner.

Authors:  Z Alourfi; R P Donn; A Stevens; A Berry; A McMaster; D W Ray
Journal:  J Mol Endocrinol       Date:  2005-04       Impact factor: 5.098

8.  Analysis of co-factor function in a glucocorticoid-resistant small cell carcinoma cell line.

Authors:  C E Waters; A Stevens; A White; D W Ray
Journal:  J Endocrinol       Date:  2004-11       Impact factor: 4.286

9.  Glucocorticoid ligands specify different interactions with NF-kappaB by allosteric effects on the glucocorticoid receptor DNA binding domain.

Authors:  Helen Garside; Adam Stevens; Stuart Farrow; Claire Normand; Benoit Houle; Andy Berry; Barbara Maschera; David Ray
Journal:  J Biol Chem       Date:  2004-09-08       Impact factor: 5.157

10.  Immunosuppressive activities of recombinant glycosylation-inhibiting factor mutants.

Authors:  T Tomura; H Watarai; N Honma; M Sato; A Iwamatsu; Y Kato; R Kuroki; T Nakano; T Mikayama; K Ishizaka
Journal:  J Immunol       Date:  1999-01-01       Impact factor: 5.422

View more
  10 in total

1.  Glucocorticoids suppress hypoxia-induced COX-2 and hypoxia inducible factor-1α expression through the induction of glucocorticoid-induced leucine zipper.

Authors:  Wonchung Lim; Choa Park; Myeong Kuk Shim; Yong Hee Lee; You Mie Lee; YoungJoo Lee
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

2.  Transcription factor ICBP90 regulates the MIF promoter and immune susceptibility locus.

Authors:  Jie Yao; Lin Leng; Maor Sauler; Weiling Fu; Junsong Zheng; Yi Zhang; Xin Du; Xiaoqing Yu; Patty Lee; Richard Bucala
Journal:  J Clin Invest       Date:  2016-01-11       Impact factor: 14.808

3.  Hypoxia stimulates the expression of macrophage migration inhibitory factor in human vascular smooth muscle cells via HIF-1alpha dependent pathway.

Authors:  Hua Fu; Fengming Luo; Li Yang; Wenchao Wu; Xiaojing Liu
Journal:  BMC Cell Biol       Date:  2010-08-20       Impact factor: 4.241

Review 4.  Hypoxia-dependent regulation of inflammatory pathways in immune cells.

Authors:  Cormac T Taylor; Glen Doherty; Padraic G Fallon; Eoin P Cummins
Journal:  J Clin Invest       Date:  2016-07-25       Impact factor: 14.808

5.  Hypoxia signaling regulates macrophage migration inhibitory factor (MIF) expression in stroke.

Authors:  Odysseus Zis; Si Zhang; Katerina Dorovini-Zis; Lijuan Wang; Weihong Song
Journal:  Mol Neurobiol       Date:  2014-05-15       Impact factor: 5.590

6.  Identification of a novel cell type-specific intronic enhancer of macrophage migration inhibitory factor (MIF) and its regulation by mithramycin.

Authors:  E Beaulieu; L Green; L Elsby; Z Alourfi; E F Morand; D W Ray; R Donn
Journal:  Clin Exp Immunol       Date:  2010-11-19       Impact factor: 4.330

7.  Cell cycle phase regulates glucocorticoid receptor function.

Authors:  Laura Matthews; James Johnson; Andrew Berry; Peter Trebble; Ann Cookson; Dave Spiller; Caroline Rivers; Michael Norman; Mike White; David Ray
Journal:  PLoS One       Date:  2011-07-29       Impact factor: 3.240

8.  The methyltransferase WBSCR22/Merm1 enhances glucocorticoid receptor function and is regulated in lung inflammation and cancer.

Authors:  Maryam Jangani; Toryn M Poolman; Laura Matthews; Nan Yang; Stuart N Farrow; Andrew Berry; Neil Hanley; Andrew J K Williamson; Anthony D Whetton; Rachelle Donn; David W Ray
Journal:  J Biol Chem       Date:  2014-01-31       Impact factor: 5.157

Review 9.  Homeostatic Regulation of Glucocorticoid Receptor Activity by Hypoxia-Inducible Factor 1: From Physiology to Clinic.

Authors:  Davide Marchi; Fredericus J M van Eeden
Journal:  Cells       Date:  2021-12-07       Impact factor: 6.600

10.  Hypoxia regulates GR function through multiple mechanisms involving microRNAs 103 and 107.

Authors:  Nan Yang; Andrew Berry; Carolin Sauer; Matthew Baxter; Ian J Donaldson; Karen Forbes; Rachelle Donn; Laura Matthews; David Ray
Journal:  Mol Cell Endocrinol       Date:  2020-08-29       Impact factor: 4.102

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.